Adenocarcinoma on needle prostatic biopsies: Does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?

International Braz J Urol

Volumn 39, Issue 3, 2013, Pages 320-327

  Billis, Athanase ^a   Meirelles, Luciana ^a   Freitas, Leandro L L ^a   Polidoro, Aline S ^a   Fernandes, Hamilton A ^a   Padilha, Mariana M ^a   Magna, Luis A ^a   Reis, Leonardo O ^a   Ferreira, Ubirajara ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Disease progression; Fibrosis; Humans; Prognosis; Prostatic Neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; CANCER GRADING; DISEASE COURSE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RISK FACTOR; STROMA CELL; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; BIOPSY, FINE-NEEDLE; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; STROMAL CELLS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84881509463     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-5538.IBJU.2013.03.04     Document Type: Article

References (21)

1. Rønnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996; 76: 69-125.
2. Martin M, Pujuguet P, Martin F: Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract. 1996; 192: 712-7.
3. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315: 1650-9.
4. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR: Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002; 8: 2912-23.
5. Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 2003; 107: 1-10.
6. Zhang Y, Nojima S, Nakayama H, Jin Y, Enza H: Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. Oncol Rep. 2003; 10: 207-11.
7. Rowley DR: What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 1998-1999; 17: 411-9.
8. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200: 429-47.
9. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, et al.: Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res. 2009; 15: 3979-89.
10. Niu YN, Xia SJ: Stroma-epithelium crosstalk in prostate cancer. Asian J Androl. 2009; 11: 28-35.
11. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999; 59: 5002-11.
12. Hayward SW, Cunha GR, Dahiya R: Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann N Y Acad Sci. 1996; 784: 50-62.
13. Cunha GR, Hayward SW, Dahiya R, Foster BA: Smooth muscle- epithelial interactions in normal and neoplastic prostatic development. Acta Anat (Basel). 1996; 155: 63-72.
14. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200: 429-47.
15. Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol. 2001; 11: 97-104.
16. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, et al.: Reactive stroma as a predictor of biochemicalfree recurrence in prostate cancer. Clin Cancer Res. 2003; 9: 4792-801.
17. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, et al.: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2007; 38: 1611-20.
18. Tomas D, Spajic B, Milosevic M, Demirovic A, Marusic Z, Kruslin B: Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma. Scand J Urol Nephrol. 2010; 44: 284-90.
19. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29: 1228-42.
20. Billis A, Magna LA, Ferreira U: Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation. Int Braz J Urol. 2003; 29: 113-9; discussion 120.
21. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, et al.: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007; 177: 540-5.